NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025

A Contract Award Notice
by NHS ENGLAND

Source
Contracts Finder
Type
Framework (Products)
Duration
2 year
Value
£4B
Sector
HEALTH
Published
29 Jul 2025
Delivery
01 Sep 2025 to 31 Aug 2027
Deadline
07 Apr 2025 12:00

Concepts

Location

Geochart for 1 buyers and 21 suppliers

1 buyer

21 suppliers

Description

NHS Framework Agreement for Branded Medicines - Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025 CM/PHR/24/5680/01 - NHS Framework Agreement for Branded Medicines - Tranche B for North of England and Midlands & East. Period of Framework Agreement: 01 September 2025 to 31 August 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/24/5680/02 - NHS Framework Agreement for Branded Medicines - Eculizumab and Ravulizumab for London & SOFE. Period of Framework Agreement: 01 September 2025 to 31 August 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months.

Award Detail

1 Biogen (Maidenhead)
  • Value: £986,282,758
2 Amgen (Cambridge)
  • Value: £986,282,758
3 Sobi Swedish Orphan Biovitrum (Great Abington)
  • Value: £986,282,758
4 Zentiva Pharma (Guildford)
  • Value: £986,282,758
5 Fresenius Kabi (Runcorn)
  • Value: £986,282,758
6 Sandoz (Western Road Bracknell)
  • Value: £986,282,758
7 Thornton & Ross (Huddersfield)
  • Value: £986,282,758
8 Roche Products (None)
  • Value: £986,282,758
9 Accord (Whiddon Valley Barnstaple)
  • Value: £986,282,758
10 Glaxosmithkline (London)
  • Value: £986,282,758
11 Samsung Bioepis (Brentford)
  • Value: £986,282,758
12 Pfizer (Tadworth)
  • Value: £986,282,758
13 Janssen Cilag (High Wycombe)
  • Value: £986,282,758
14 Celltrion Healthcare (Uxbridge)
  • Value: £986,282,758
15 Abbvie (None)
  • Value: £986,282,758
16 Takeda (Kingdom Street London)
  • Value: £986,282,758
17 Organon Pharmaceuticals (London)
  • Value: £986,282,758
18 Alexion Pharmaceuticals (London)
  • Value: £986,282,758
19 Orifarm (Breakspear Park Hemel Hempstead)
  • Value: £986,282,758
20 Curateq Biologics Sro (Prague)
  • Value: £986,282,758
21 Drreddys Laboratories (Cambridge)
  • Value: £986,282,758

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Contract is suitable for SMEs.

Other Information

Framework Agreement and Terms and Conditions - Tranche B - 1 September 2025 Framework Agreement and Terms and Conditions - Tranche B - 1 September 2025.pdf Tranche B -Transparency Award Schedules - CM_PHR_24_5680_01 Tranche B -Transparency Award Schedules - CM_PHR_24_5680_01.pdf Tranche B -Transparency Award Schedules - CM_PHR_24_5680_02 Tranche B -Transparency Award Schedules - CM_PHR_24_5680_02.pdf

Reference

Domains